menu search

CWBR / Why Is CohBar (CWBR) Stock Up 130% Today?

Why Is CohBar (CWBR) Stock Up 130% Today?
CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see the two combine to create a new company named “TuHURA Biosciences, Inc.” This company will continue to trade its shares on The Nasdaq Capital Market. Read More
Posted: May 23 2023, 11:44
Author Name: InvestorPlace
Views: 081886

CWBR News  

Why Is CohBar (CWBR) Stock Up 130% Today?

By InvestorPlace
May 23, 2023

Why Is CohBar (CWBR) Stock Up 130% Today?

CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis a more_horizontal

CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference

By GlobeNewsWire
September 6, 2022

CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference

MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the more_horizontal

CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 16, 2022

CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript

CohBar Inc. (NASDAQ:CWBR ) Q1 2022 Results Conference Call May 16, 2022 5:00 PM ET Company Participants Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahak more_horizontal

CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 29, 2022

CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript

CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: